What Has Driven the Growth of the Tuberculosis Diagnostics Market in Recent Years?
The tuberculosis diagnostics market has seen considerable growth due to a variety of factors.
• There has been a significant expansion in the size of the tuberculosis diagnostics market in the past few years. The market, which was worth $2.21 billion in 2024, is projected to increase to $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
Factors such as a higher occurrence of tuberculosis, a rise in health care spending, an increase in the number of health care facilities, and a growing adoption of nucleic acid testing all contributed to the growth seen in the historical period.
What are the Market Size and Expected Growth Rates for the Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated robust growth in the tuberculosis diagnostics market is predicted to elevate its size to $3.24 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%.
The significant expansion during the forecast period can be attributed to factors such as strong governmental backing, escalating FDA approvals for tuberculosis diagnostics, augmented research and development (R&D) activities, and the advent of drug-resistant TB. Current trends impacting this expected growth include a shift in focus towards next-generation sequencing (NGS) platforms for TB diagnostics, the introduction of innovative products, t-cell testing for TB infection, utilization of artificial intelligence (AI) in tuberculosis diagnostics, application of portable devices, and partnerships between governmental bodies and manufacturers.
What Are The Primary Growth Drivers In The Tuberculosis Diagnostics Market?
The increase in tuberculosis cases is propelling the tuberculosis diagnostics market forward. Tuberculosis, an infectious disease primarily impacting the lungs, is quite severe and spreads via coughing and sneezing, releasing minute germs into the air. Tuberculosis diagnostics assist in identifying patients, enabling earlier disease diagnosis and detection. For example, the Centers for Disease Control and Prevention, a national public health organization based in the United States, reported 8,300 cases of tuberculosis (TB) in the U.S in March 2023, showing an increase from 7,874 cases in 2021. Thus, the escalating incidence of tuberculosis is propelling the tuberculosis diagnostics market. Hence, the growing occurrence of tuberculosis is fostering the expansion of the tuberculosis diagnostics market.
What Are The Key Segments Within The Global Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
Pre-Book The Tuberculosis Diagnostics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Tuberculosis Diagnostics Market?
Technological progress is the primary trend gaining traction in the tuberculosis diagnostics market. Major entities in this market utilize breakthrough technologies like advanced point-of-care (POC) diagnostic techniques using AI technology to maintain their market standing. For instance, in August 2022, Fujifilm, a Japanese firm specializing in producing medical imaging equipment, teamed up with Qure.ai, a US-based enterprise specializing in creating AI-powered medical imaging solutions. They introduced an innovative point-of-care (POC) diagnostic approach, utilizing a battery-operated X-ray device for diagnosing tuberculosis. By leveraging artificial intelligence, algorithms facilitate effective testing processes while ensuring ultra-portability, high precision, and efficient point-of-care diagnostic solutions.
Who Are the Key Players in the Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market include:
• Beckton
• Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Qiagen N.V
• BioMerieux SA
• Danaher Corporation
• PerkinElmer
• Thermo Fisher Scientific Inc.
• Creative Diagnostics
• Lionex GmbH
• Biocartis
• Bio-Techne India Private Limited
• Bio-Rad laboratories India Pvt.Ltd
• Zhejiang Di'an Diagnostics Technology Co. Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global
• OriGene Technologies
• Siemens AG
• LumiraDx Limited
• TestLine Clinical Diagnostics s.r.o.
• Hologic
• Bayer AG
• Meridian Bioscience
• Abbott laboratories Immunodiagnostic Systems Holdings PLC
• Mesa Biotech Inc
• Agilent technologies Inc
• Akonni Biosystems Inc
• Epistem Limited
• Gen-Probe
• Sysmex South Africa (Pty) Ltd.
• Bio Certica
• BixBio
What are the Regional Insights into the Tuberculosis Diagnostics Market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
